About US
Contact us
-
Nabi Biopharmaceuticals completes sale of PentaStaph vaccine candidate to GSKNabi Biopharmaceuticals (Nasdaq:NABI) announced today that it has successfully completed the technology transfer of program know-how associated with the sale of the PentaStaphTM vaccine candidate to G2010/8/12
-
Weifang Shengtai to supply Kelun with 10,000 tons of dextrose monohydrate injection gradeShengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) announced on August 6, 2010 that Weifang Shengtai Pharmaceutical Co., Ltd ("Weifang Shengtai"), its operating subsidiary in China, entered into2010/8/11
-
FDA grants Orphan Drug Designation to YM BioSciences' JAK1/2 inhibitor-JAK1/2 inhibitor currently in Phase II clinical study in myelofibrosis- YM BioSciences Inc. (NYSE Amex: YMI, TSX:YM), announced that the Office of Orphan Products Development of the U.S. Food and Dr2010/8/11
-
Mephedrone regulated as psychotropic substancesOn August 2, 2010, the State Food and Drug Administration, the Ministry of Public Security and the Ministry of Health jointly issued an announcement, which requires that Mephedrone (4-methylmethcath2010/8/10
-
FDA approves Pfizer's Prefilled Dual-Chamber Syringe for XYNTHA administration in hemophilia A patientsPfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has granted approval of the use of a Prefilled Dual-Chamber Syringe for administration of XYNTHA® Antihemop2010/8/10
-
FDA accepts Salix's XIFAXAN550 sNDA for Priority ReviewSalix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Company's efficacy supplement to the New Drug Application (ND2010/8/10
-
FDA seeks ban on Regenerative Sciences for violating cGMPThe U.S. Food and Drug Administration is seeking an injunction in federal court against Regenerative Sciences LLC, of Broomfield, Colo., citing violations of current good manufacturing practice (cGMP)2010/8/9
-
FDA confirms Advisory Committee meeting date for lorcaserin NDA reviewArena Pharmaceuticals, Inc. (Nasdaq: ARNA) and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has notified the company of the confirmed scheduling of an Endocrinologic and M2010/8/9
-
BMS to join ranks of AIDS drug companies to offer price concessionsFollowing ongoing advocacy campaigns spearheaded by AIDS Healthcare Foundation (AHF) that targeted several of the largest AIDS drug companies over their pricing and rebate policies for the nation's AI2010/8/9
-
Evonik steps up its commitment to corporate responsibility (CR)CR report 2009 published CR program for the next few years presented Evonik is aligning its business portfolio to megatrends and thus making a contribution to sustainable development Essen. I2010/8/6